The most influential Megatrends set to shape the world through 2030, identified by Euromonitor International, help businesses better anticipate market developments and lead change for their industries.
Learn moreEuromonitor addresses your unique questions and challenges across all B2B and B2C industries and geographies through custom, tailor-made research projects, designed to your specific goals.
Learn moreJan 2021
US$2,650Added to Cart
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!
In response to COVID-19 the Swiss government introduced a range of measures to limit the spread of the virus, with this having a mixed impact on the various categories of consumer health. Nonetheless, there was an overall improvement seen in 2020, spurred on by stronger sales in key categories including analgesics, cough, cold and allergy (hay fever) remedies, and vitamins.
On 13 March, the Swiss government introduced controls at all of its Schengen borders. Entry into Switzerland from Italy from this date was only allowed for Swiss citizens, people with a residence permit or people travelling to Switzerland for professional reasons, with this extended to the German, French and Austrian borders from 16 March.
COVID-19 created a great deal of uncertainty across the globe and in Switzerland with people unsure of how long it will continue to disrupt their everyday lives and what risk it poses to them and their friends and family. In this environment most consumers turned to well-known brands that they were familiar with and that they trusted, with this limiting the potential for smaller players and new entrants.
The sale of most OTC products are strictly regulated, with distribution largely limited to chemists/pharmacies and drugstores/parapharmacies, with products such as wound care being one of the few exceptions. As such, despite the challenges presented by COVID-19 there was little movement in the distribution landscape for OTC products.
Prior to the outbreak of COVID-19 in Switzerland there had been a general movement towards more natural solutions to health, with a growing focus on prevention over cure. The outbreak of COVID-19 disrupted this pattern as consumers rushed to address their immediate concerns.
Files are delivered directly into your account within a few minutes of purchase.
Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.
Delivery: Files are delivered directly into your account within a few minutes of purchase.
Overview
Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Switzerland with research from Euromonitor's team of in-country analysts.
Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.
If you're in the Consumer Health industry in Switzerland, our research will save you time and money while empowering you to make informed, profitable decisions.
When you purchase this report, you also get the data and the content from these category reports in Switzerland for free:
The Consumer Health in Switzerland market research report includes:
Our market research reports answer questions such as:
Why buy this report?
This industry report originates from Passport, our Consumer Health market research database.
Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.